- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05505851
Sequential Core Stability Corrective Exercise Approach in Lower Crossed Syndrome (SCSCRLCS)
Sequential Core Stability Corrective Exercise Approach for Alignment And Muscle Function In Lower Crossed Syndrome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Lower Crossed Syndrome is one of common postural disorder which occurs due to the muscular imbalance. It refers to specific altered muscle activation and movement patterns along with some postural deviations. Alterations in muscle activation include overactivity of hip flexors and lower back muscles paired underactivity of abdominals and gluteus muscle. This pattern of imbalance creates dysfunction. Postural correction exercise with inner and outer core muscles are necessary. There are different traditional structural approach, functional approach and biomechanics and are presumed to lead to adjustments in the length and strength of local muscles while ignoring other related malalignments and core stability. The objective of the study will be to determine the effects of Sequential Core Stability Corrective Exercise Approach for Alignment and Muscle Function in Lower Crossed Syndrome.
It will be a randomized controlled trial. Sample size will be collected after running the pilot study. The participants will be recruited through convenient sampling technique and then allocated randomly to Groups. Outcome measures will be alignment and muscle function. Pre and post reading and after one month follow-up will be recorded. Data will be analyzed using statistical package for social sciences software version 25. After assessing normality of data by Shapiro-Wilk test, it will be decided either parametric or nonparametric test will be use within a group or between two groups.
Keywords: Alignment, Core Stability, Diaphragm, Muscular Imbalance, Muscle thickness Pelvic floor.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Al-khumeini Trust Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
• Age group between 18 to 28 years
- No current incidence of low back pain or past history of low back dysfunction
- Kendall double leg lowering test: Abdominal muscle weakness to the extent of not being able to maintain posterior pelvic tilt during a double leg lowering test in supine position.
- Diagnosed with lower cross syndrome through assessment criteria of Janda muscle testing and assessment
Exclusion Criteria:
• Having any history of low back pain, spinal trauma,
- Joint dysfunction in past 3 months
- Congenital deformities at hip or lumbar region,
- Recent fracture to related joints in past 6 months
- Any family history of cardiopulmonary disease
- Any disease or urogenital tract
- Participants having BMI above 30.
- Recent history of hepatitis or Fatty liver or
- Any athlete having high physical activity.
- History of abdominal, hip or lumbar surgeries in past 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: A: Control
Corrective Exercises: Hip Flexor Stretch, Thoracolumbar Extensor Stretch, Abdominal Curl, and Glute Bridge. |
Corrective Exercises: Hip Flexor Stretch, Thoracolumbar Extensor Stretch, Abdominal Curl, and Glute Bridge.
|
|
Experimental: B: Sequential Core Stability Corrective Exercise Approach
Sequential Core Stability Corrective Exercise Approach
|
Sequential Core Stability Corrective Exercise Approach
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Photometry for Pelvic Tilt
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
|
Angle of Pelvic tilt will be measured Through a Reliable and validated camera.
|
Pre (0th week), Post (6th week), (12th week) Follow-up
|
|
Photometry for Chest Expansion
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
|
Angle of Chest expansion will be measured at Nipple line, Xiphoid level and at waist level, Through a Reliable and validated camera.
|
Pre (0th week), Post (6th week), (12th week) Follow-up
|
|
Photometry for Cervicothoracic level
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
|
Angle of C7-T1 will be measured Through a Reliable and validated camera.
|
Pre (0th week), Post (6th week), (12th week) Follow-up
|
|
Photometry for Lumber flexion
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
|
Angle of Lumber curve will be measured Through a Reliable and validated camera.
|
Pre (0th week), Post (6th week), (12th week) Follow-up
|
|
Diaphragmatic excursion
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
|
To assess the diaphragmatic motion by M-mode US a 2.5-5 megahertz (MHz) phase array will be used.
|
Pre (0th week), Post (6th week), (12th week) Follow-up
|
|
Levator ani Excursion
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
|
To assess the pelvic floor motion by M-mode US a 2.5-5 megahertz (MHz) array will be used.
|
Pre (0th week), Post (6th week), (12th week) Follow-up
|
|
Diaphragmatic thickness and thickening
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
|
diaphragmatic thicknesses and thickening will be assessed by B-mode ultrasonography during various respiratory maneuvers
|
Pre (0th week), Post (6th week), (12th week) Follow-up
|
|
Levator ani thickness and thickening
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
|
Levator ani thicknesses and thickening will be assessed by B-mode ultrasonography during various respiratory maneuvers
|
Pre (0th week), Post (6th week), (12th week) Follow-up
|
|
Core stability
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
|
It will be measured by Pressure biofeedback unit for the transverse abdomens.
|
Pre (0th week), Post (6th week), (12th week) Follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Forced Vital Capacity (FVC)
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
|
Pulmonary function test through spirometer, It will be measured by digital spirometer.
|
Pre (0th week), Post (6th week), (12th week) Follow-up
|
|
Forced Expiratory Volume per second FEV1
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
|
Pulmonary function test through spirometer, It will be measured by digital spirometer.
|
Pre (0th week), Post (6th week), (12th week) Follow-up
|
|
Ratio of FEV1/ FVC
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
|
Pulmonary function test through spirometer, It will be measured by digital spirometer.
|
Pre (0th week), Post (6th week), (12th week) Follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Wajeeha Zia, PhD*, Riphah International University , QIE, Campus
- Study Chair: Muhammad Kashif, PhD, Riphah International University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/RCR & AHS/22/1104
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.